Using the risk factors such as history of gross hematuria, age, sex, smoking history and high grade hematuria, a Hematuria risk Index was created to predict cancer risk.12 According to this Hematuria risk Index, low-grade hematuria (<25 RBC/HPF) was not a reliable indicator of the presence of urologic malignant tumors, the overall 3-year incidence of urinary tract cancer was only 0.43%.13 In this study we found that women with prolapse are more likely to be diagnosed with AMH but hematuria is low grade (<25 RBC/HPF) in all patients, which doesn’t mean high risk for urologic malignant tumors. The gene discussed is AMH; the disease is Hematuria.